297 related articles for article (PubMed ID: 29704469)
1. Current treatment of ocular toxoplasmosis in immunocompetent patients: a network meta-analysis.
Zhang Y; Lin X; Lu F
Acta Trop; 2018 Sep; 185():52-62. PubMed ID: 29704469
[TBL] [Abstract][Full Text] [Related]
2. A systematic review and meta-analysis of the relative efficacy and safety of treatment regimens for HIV-associated cerebral toxoplasmosis: is trimethoprim-sulfamethoxazole a real option?
Hernandez AV; Thota P; Pellegrino D; Pasupuleti V; Benites-Zapata VA; Deshpande A; Penalva de Oliveira AC; Vidal JE
HIV Med; 2017 Feb; 18(2):115-124. PubMed ID: 27353303
[TBL] [Abstract][Full Text] [Related]
3. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis.
Soheilian M; Sadoughi MM; Ghajarnia M; Dehghan MH; Yazdani S; Behboudi H; Anisian A; Peyman GA
Ophthalmology; 2005 Nov; 112(11):1876-82. PubMed ID: 16171866
[TBL] [Abstract][Full Text] [Related]
4. A Systematic Review and Meta-Analysis of the Efficacy of Anti-Toxoplasma gondii Medicines in Humans.
Wei HX; Wei SS; Lindsay DS; Peng HJ
PLoS One; 2015; 10(9):e0138204. PubMed ID: 26394212
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of trimethoprim/ sulfamethoxazole treatment for ocular toxoplasmosis in Congolese patients.
Nsiangani Lusambo N; Kaimbo Wa Kaimbo D; Ngoyi Mumba DM; de-la-Torre A
BMC Ophthalmol; 2023 Oct; 23(1):440. PubMed ID: 37907920
[TBL] [Abstract][Full Text] [Related]
6. A study for precision diagnosing and treatment strategies in difficult-to-treat AIDS cases and HIV-infected patients with highly fatal or highly disabling opportunistic infections.
Li Y; Zeng YM; Lu YQ; Qin YY; Chen YK
Medicine (Baltimore); 2020 May; 99(20):e20146. PubMed ID: 32443329
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic approaches for AIDS-related toxoplasmosis.
Behbahani R; Moshfeghi M; Baxter JD
Ann Pharmacother; 1995; 29(7-8):760-8. PubMed ID: 8520094
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of prevention and treatment of toxoplasmic encephalitis in HIV-infected patients.
Yan J; Huang B; Liu G; Wu B; Huang S; Zheng H; Shen J; Lun ZR; Wang Y; Lu F
Acta Trop; 2013 Sep; 127(3):236-44. PubMed ID: 23707647
[TBL] [Abstract][Full Text] [Related]
9. [Presumed toxoplasmic chorioretinitis: comparative study of treatment with pyrimethamine and sulfadiazine or clindamycin].
Colin J; Harie JC
J Fr Ophtalmol; 1989; 12(3):161-5. PubMed ID: 2695556
[TBL] [Abstract][Full Text] [Related]
10. Trimethoprim-sulfamethoxazole therapy for ocular toxoplasmosis.
Opremcak EM; Scales DK; Sharpe MR
Ophthalmology; 1992 Jun; 99(6):920-5. PubMed ID: 1630782
[TBL] [Abstract][Full Text] [Related]
11. Synergistic sulfonamides plus clindamycin as an alternative therapeutic regimen for HIV-associated Toxoplasma encephalitis: a randomized controlled trial.
Li Y; Zeng Y; Lu Y; He X; Wu Y; Zhang W; Huang Y; Chen H; Chen Y
Chin Med J (Engl); 2022 Nov; 135(22):2718-2724. PubMed ID: 36574221
[TBL] [Abstract][Full Text] [Related]
12. A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis.
Bosch-Driessen LH; Verbraak FD; Suttorp-Schulten MS; van Ruyven RL; Klok AM; Hoyng CB; Rothova A
Am J Ophthalmol; 2002 Jul; 134(1):34-40. PubMed ID: 12095805
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of Treatments for Ocular Toxoplasmosis.
Casoy J; Nascimento H; Silva LMP; Fernández-Zamora Y; Muccioli C; Dias JRO; Nóbrega MJ; Nóbrega HAJ; Zummo J; Belfort R
Ocul Immunol Inflamm; 2020; 28(2):249-255. PubMed ID: 30806556
[No Abstract] [Full Text] [Related]
14. Therapy for ocular toxoplasmosis.
Rothova A; Meenken C; Buitenhuis HJ; Brinkman CJ; Baarsma GS; Boen-Tan TN; de Jong PT; Klaassen-Broekema N; Schweitzer CM; Timmerman Z
Am J Ophthalmol; 1993 Apr; 115(4):517-23. PubMed ID: 8470726
[TBL] [Abstract][Full Text] [Related]
15. Current Practices in Ocular Toxoplasmosis: A Survey of Brazilian Uveitis Specialists.
Morais FB; Arantes TEFE; Muccioli C
Ocul Immunol Inflamm; 2018; 26(2):317-323. PubMed ID: 27598330
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of different antibiotic regimens in patients with ocular toxoplasmosis: systematic review and meta-analysis.
Feliciano-Alfonso JE; Muñoz-Ortiz J; Marín-Noriega MA; Vargas-Villanueva A; Triviño-Blanco L; Carvajal-Saiz N; de-la-Torre A
Syst Rev; 2021 Jul; 10(1):206. PubMed ID: 34275483
[TBL] [Abstract][Full Text] [Related]
17. Management of toxoplasmic encephalitis in HIV-infected adults (with an emphasis on resource-poor settings).
Dedicoat M; Livesley N
Cochrane Database Syst Rev; 2006 Jul; (3):CD005420. PubMed ID: 16856096
[TBL] [Abstract][Full Text] [Related]
18. Sulfadiazine plasma concentrations in women with pregnancy-acquired compared to ocular toxoplasmosis under pyrimethamine and sulfadiazine therapy: a case-control study.
Reiter-Owona I; Hlobil H; Enders M; Klarmann-Schulz U; Gruetzmacher B; Rilling V; Hoerauf A; Garweg JG
Eur J Med Res; 2020 Nov; 25(1):59. PubMed ID: 33228795
[TBL] [Abstract][Full Text] [Related]
19. Adverse drug reactions to treatments for ocular toxoplasmosis: a retrospective chart review.
Iaccheri B; Fiore T; Papadaki T; Androudi S; Janjua S; Bhaila I; Stephen Foster C
Clin Ther; 2008 Nov; 30(11):2069-74. PubMed ID: 19108794
[TBL] [Abstract][Full Text] [Related]
20. Alternative treatment approach to cerebral toxoplasmosis in HIV/AIDS: experience from a resource-poor setting.
Goswami RP; Goswami RP; Rahman M; Ray Y; Tripathi SK
Int J STD AIDS; 2015 Oct; 26(12):864-9. PubMed ID: 25411350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
